Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease (Q36304299)

13 August 2017

1 reference

title

Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease (English)

1 reference

13 August 2017

Begoña López

3

0 references

author name string

Javier Díez

series ordinal

1

1 reference

13 August 2017

Arantxa González

series ordinal

2

1 reference

13 August 2017

Ramón Querejeta

series ordinal

4

1 reference

13 August 2017

publication date

1 April 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

209-216

1 reference

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Fibrosis and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Chronic AT 1 Blockade Stimulates Extracellular Collagen Type I Degradation and Reverses Myocardial Fibrosis in Spontaneously Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Regulation of cardiovascular collagen synthesis by mechanical load

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

The biochemical response of the heart to hypertension and exercise

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Profibrotic effects of angiotensin II in the heart: a matter of mediators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Induction of cardiac fibrosis by aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Fibrosis and ischemia: the real risks in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Cardiac fibrosis as a cause of diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Connective tissue and the heart. Functional significance and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Histopathological factors related to diastolic function in myocardial hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Collagen deposition and the reversal of coronary reserve in cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Defining "culprit mechanisms" in arrhythmogenic cardiac remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Ultrasonic tissue characterization: review of an approach to assess hypertrophic myocardium

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Review of methods for texture analysis of myocardium from echocardiographic images: a means of tissue characterization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Cardiovascular magnetic resonance and the evaluation of heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Biochemical assessment of myocardial fibrosis in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0158

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0158

1 reference

13 August 2017

1 reference